Learn more about whether Charles River Laboratories International, Inc. or Illumina, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics ...
Zacks Investment Research on MSN
Here's why Illumina (ILMN) is a strong momentum stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...
Illumina (ILMN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in ...
Why Illumina’s Latest Move Has Investors Watching Closely Illumina (ILMN) just deepened its bet on clinical whole genome sequencing by investing in and partnering with MyOme, backing a large Proactive ...
Fintel reports that on December 22, 2025, Canaccord Genuity maintained coverage of Illumina (NasdaqGS:ILMN) with a Hold ...
In a report released today, from Jefferies maintained a Hold rating on Illumina, with a price target of $125.00. In addition to Jefferies, Illumina also received a Hold from J.P. Morgan’s Casey ...
Standard BioTools has a very small Wall Street following as can be seen above. On average, they expect the company to lose $0 ...
In a report released today, Luke Sergott from Barclays maintained a Sell rating on Illumina, with a price target of $110.00. Sergott covers the Healthcare sector, focusing on stocks such as Illumina, ...
Illumina Q3 earnings beat estimates, prompting Cwm LLC to boost its stake by 43.9%. Discover why analysts maintain a 'Hold' ...
Pacific Biosciences of California, Inc. is downgraded to Hold with slow commercial adoption & academic funding pressures.
Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback